| Quote | Spy HEB NEW ![]() |
Message Board | |||||
|
Visit a stock's Spy page to see who else is tracking it and who else is talking about it. Spy pages also list institutional holders. |
|
Hemispherx Biopharma Reports a Q3 Loss; Comments on FDA Responses
HEB Linked by StreetInsider - November 09, 03:08PM from (www.streetinsider.com) more ...
The $2000 Swine Flu Drug
BAX GILD BCRX APT RHHBY HEB DVAX INO SVA Linked by tickerspy blog - November 05, 09:53AM from (www.tickerspy.com) The peramivir pricing speculation is over, and the first order has been shipped. The U.S. FDA issued more ...
Swine Flu Small-Cap Jumps on FDA Announcement
VICL GILD BCRX APT RHHBY HEB DVAX GSK Linked by tickerspy blog - October 26, 09:43AM from (www.tickerspy.com) An Alabama-based small-cap biotech play was granted emergency use authorization for its H1N1 antiviral. more ...
Flu Stocks in Focus as Orders, Approvals Stack Up
BAX VICL BCRX HEB NVAX SVA GSK Linked by tickerspy blog - October 07, 10:13AM from (www.tickerspy.com) Peak flu season is approaching, and investor focus is returning to related equity plays. Baxter International more ...
BioCryst takes on Tamiflu
VICL APT RHHBY HEB PURE INO SVA Linked by tickerspy blog - September 14, 11:43AM from (www.tickerspy.com) Peramivir could be the next swine flu-fighting one-dose wonder. BioCryst Pharmaceuticals (NADSAQ: BCRX) more ...
In Absence of Flu News, Vaccine Stocks Still Soar
QDEL APT HEB DVAX CPHD GNBT NVS GSK IMA Linked by tickerspy blog - September 10, 10:43AM from (www.tickerspy.com) It's not all swine flu for these vaccine companies, and Thursday's moves proved it. Safety concerns put more ...
China's Vaccine Approval Sends Flu Stocks Soaring
VICL AVII APT HEB DVAX SVA NVS GSK Linked by tickerspy blog - August 31, 12:43PM from (www.tickerspy.com) Flu news from China has driven the market higher over the last week, today sending stocks up by as much as 30%. more ...
Investment Performance Update
HEB NEPH SPNG SOMX BIEL Linked by StocksHaven - August 18, 03:36AM from (www.stockshaven.com) StocksHaven Investments takes a closer look at the past performances in (OTC:SPNG), (NASDAQ:MESA), (AMEX:HEB), (OTC:ACCP), more ...
It's Not All Swine Flu for Vaccine Stocks
BCRX AZN HEB NVAX DVAX INO NVS SNY Linked by tickerspy blog - August 05, 11:43AM from (www.tickerspy.com) Vaccine stocks were mixed mid-week, some on flu-related news, others not. After the bell yesterday, more ...
Sinovac initiates dosing in human clinical trials
BCRX HEB NVAX SVA Linked by Vertcap - July 22, 12:28PM from (finance.yahoo.com) Sinovac initiates dosing in human clinical trials as World watches vaccine makers closely. Other Vaccine makers such as Biocryst, more ...
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Home | About | Register | My tickerspy | Logout | Web site design by LightMix |
| © 2009 Indie Research, LLC. All rights reserved. | |
---
Institutional Holdings Disclaimer Pro portfolios track the top 15 quarterly holdings of more than 1,400 institutions. Comments in Pro portfolios show the institution's change in shares held for each company quarter over quarter. Pro portfolio performance is based on institutions' top 15 holdings as disclosed in quarter-end filings with the SEC. Pro performance does not take into account additional holdings beyond the top 15 nor does it include positions that are not required to be disclosed by the SEC. As such, Pro portfolio performance should be considered an approximation and not a precise record of how an institution has performed over time. tickerspy is not affiliated with any of the Pro investors profiled on our web site. The performance data and graph are estimates and do not represent an advertisement or endorsement by either tickerspy or the Pro investors. THE INFORMATION PROVIDED TO YOU HEREUNDER IS PROVIDED "AS IS" AND TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, INDIE RESEARCH, LLC AND IT LICENSORS, BUSINESS ASSOCIATES AND SUPPLIERS DISCLAIM ALL WARRANTIES WITH RESPECT TO THE SAME, EXPRESS, IMPLIED AND STATUTORY, INCLUDING WITHOUT LIMITATION ANY IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, ACCURACY, COMPLETENESS AND NON-INFRINGEMENT. TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, NEITHER INDIE RESEARCH, LLC NOR ITS OFFICERS, MEMBERS, DIRECTORS, PARTNERS, AFFILIATES, BUSINESS ASSOCIATES, LICNESORS OR SUPPLIERS WILL BE LIABLE FOR ANY INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL OR PUNITIVE DAMAGES, INCLUDING WITHOUT LIMITATION DAMAGAES FOR LOST PROFITS OR REVENUES, GOODWILL, WORK STOPPAGE, SECURITY BREACHES, VIRUSES, COMPUTER FAILURE OR MALFUNCTION, USE, DATA OR OTHER INTANGIBLE LOSSES OR COMMERCIAL DAMAGES, EVEN IF ANY OF SUCH PARTIES ADVISED OF THE POSSIBILITY OF SUCH LOSSES, ARISING UNDER OR IN CONNECTION WITH THE INFORMATION PROVIDED HEREIN OR ANY OTHER SUBJECT MATTER HEREOF. |
|